WYPH Company Profile and Key Details
WayPoint Biomedical
Price Chart
Stock Price Today
WayPoint Biomedical Holdings, Inc. (WYPH) stock remained unchanged at $0.00 a share on OTC. The stock opened at $0.00, fluctuating between $0.00 to $0.00 during the session.
Stock Snapshot
Relevant Articles
SEC Fillings
Current Report (8-k)
| Filing Date | Accepted Date | |
|---|---|---|
Annual Report (10-k)
| Filing Date | Accepted Date | |
|---|---|---|
Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 40K |
| Jul 22, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 19.81K |
| Jul 15, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 1.33K |
| Jun 22, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 1.58K |
| Jun 11, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 19.8K |
| May 12, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 3K |
| May 11, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 266 |
| Apr 16, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 3K |
| Apr 07, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 5K |
| Mar 25, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 9K |
| Mar 09, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 300 |
| Mar 02, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 6.33K |
| Dec 29, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 300K |
| Dec 12, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 500 |
| Dec 08, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 300 |
| Nov 17, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 1K |
| Nov 07, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 3.33K |
| Nov 03, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 88.97K |
| Oct 31, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 8.94K |
| Oct 27, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 11.3K |
Contact Details
About Company
WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests for cocaine and marijuana detection. The company also develops and commercializes test kits for detection against possible explosive devices, biowarfare/bioterrorism agents, and the detection of weapons of mass destruction. In addition, it provides Frontline Explosive Test Kit for the detection of explosive residues. The company offers its products to the over-the-counter diagnostic self-testing, the diagnostic point of care, and the homeland security and defense markets. WayPoint Biomedical Holdings was founded in 2004 and is based in Huntington Beach, California.
Company Information
| Employees | 1 |
| Beta | -0.97 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | N/A |
| Fiscal Year Ends | N/A |
| Sector | Industrials |
| Industry | Specialty Business Services |
Stock Peers
Frequently Asked Questions
Chief Executive Officer
Mr. Phill Richer
Director of Sales and Marketing
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep